Intranasal ketamine as a treatment for psychiatric complications of long COVID: A case report

• Päätekijät: Baldwin Kaitlyn PharmD (Tekijä), Wanson Annabelle MD, FRCPC (Tekijä), Gilecki Lee-Anne MD, FRCPC (Tekijä), Dalton Courtney BSP (Tekijä), Peters Evyn MD, FRCPC (Tekijä), Halpape Katelyn BSP, ACPR, PharmD, BCPP (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: American Association of Psychiatric Pharmacists, 2023-10-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Background Neuropsychiatric symptoms associated with long COVID are a growing concern. A proposed pathophysiology is increased inflammatory mediators. There is evidence that typical serotonergic antidepressants have limited efficacy in the presence of inflammation. Although ketamine has shown promis...